glp 1 drugs australia Guide to weight loss medication in • Vively Supporting patients through GLP-1 agonist

Description

Potentially one the most debated points regarding the GLP-1 RA guidelines is how the recommended discontinuation of these medications may impact those with confounding conditions who may truly need them for either obesity management, glycemic control and possible benefits in heart failure, and chronic renal disease

It also adds warmth and sweetness without sugar, making healthy foods more satisfying

(Kruisselbrink et al

95% CI 0.99, 0.4), GLP-1 Ras/metformin (WMD: 0.14

In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future